123 related articles for article (PubMed ID: 8324416)
1. Bone mass in females with different thyroid disorders: influence of menopausal status.
Campos-Pastor MM; Muñoz-Torres M; Escobar-Jiménez F; Ruiz de Almodóvar M; Jódar Gimeno E
Bone Miner; 1993 Apr; 21(1):1-8. PubMed ID: 8324416
[TBL] [Abstract][Full Text] [Related]
2. Effect of TSH-suppressive doses of levothyroxine on bone mineral density in Thai women.
Ongphiphadhanakul B; Puavilai G; Rajatanavin R
J Med Assoc Thai; 1996 Sep; 79(9):563-7. PubMed ID: 8996984
[TBL] [Abstract][Full Text] [Related]
3. Bone mass after long-term euthyroidism in former hyperthyroid women treated with (131)I influence of menopausal status.
Serraclara A; Jódar E; Sarabia F; Hawkins F
J Clin Densitom; 2001; 4(3):249-55. PubMed ID: 11740067
[TBL] [Abstract][Full Text] [Related]
4. A therapeutic dilemma: suppressive doses of thyroxine significantly reduce bone mineral measurements in both premenopausal and postmenopausal women with thyroid carcinoma.
Diamond T; Nery L; Hales I
J Clin Endocrinol Metab; 1991 Jun; 72(6):1184-8. PubMed ID: 2026740
[TBL] [Abstract][Full Text] [Related]
5. High-normal free thyroxine levels are associated with low trabecular bone scores in euthyroid postmenopausal women.
Hwangbo Y; Kim JH; Kim SW; Park YJ; Park DJ; Kim SY; Shin CS; Cho NH
Osteoporos Int; 2016 Feb; 27(2):457-62. PubMed ID: 26252978
[TBL] [Abstract][Full Text] [Related]
6. Bone loss in hyperthyroid patients and in former hyperthyroid patients controlled on medical therapy: influence of aetiology and menopause.
Jódar E; Muñoz-Torres M; Escobar-Jiménez F; Quesada-Charneco M; Lund del Castillo JD
Clin Endocrinol (Oxf); 1997 Sep; 47(3):279-85. PubMed ID: 9373448
[TBL] [Abstract][Full Text] [Related]
7. Age-related changes in bone density among healthy Greek males.
Krassas GE; Papadopoulou FG; Doukidis D; Konstantinidis TH; Kalothetou K
J Endocrinol Invest; 2001 May; 24(5):326-33. PubMed ID: 11407652
[TBL] [Abstract][Full Text] [Related]
8. [Study on risk factors of cardiovascular disease and the status of bone mineral density in women with hypoestrogenism].
Zhao F; Guo XT; Cheng Y; Yang ZF; Liu HP
Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):734-9. PubMed ID: 24406128
[TBL] [Abstract][Full Text] [Related]
9. Bone mineral density in postmenopausal women treated with L-thyroxine.
Adlin EV; Maurer AH; Marks AD; Channick BJ
Am J Med; 1991 Mar; 90(3):360-6. PubMed ID: 2003518
[TBL] [Abstract][Full Text] [Related]
10. Skeletal integrity in premenopausal and postmenopausal women receiving long-term L-thyroxine therapy.
Greenspan SL; Greenspan FS; Resnick NM; Block JE; Friedlander AL; Genant HK
Am J Med; 1991 Jul; 91(1):5-14. PubMed ID: 1858829
[TBL] [Abstract][Full Text] [Related]
11. Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma.
Chen CH; Chen JF; Yang BY; Liu RT; Tung SC; Chien WY; Lu YC; Kuo MC; Hsieh CJ; Wang PW
J Formos Med Assoc; 2004 Jun; 103(6):442-7. PubMed ID: 15278189
[TBL] [Abstract][Full Text] [Related]
12. Determination of bone mineral density by quantitative computed tomography and single photon absorptiometry in subclinical hyperthyroidism: a risk of early osteopaenia in post-menopausal women.
Lehmke J; Bogner U; Felsenberg D; Peters H; Schleusener H
Clin Endocrinol (Oxf); 1992 May; 36(5):511-7. PubMed ID: 1617803
[TBL] [Abstract][Full Text] [Related]
13. Bone mineral density in male patients with L-thyroxine suppressive therapy and Graves disease.
Jódar E; Martínez-Díaz-Guerra G; Azriel S; Hawkins F
Calcif Tissue Int; 2001 Aug; 69(2):84-7. PubMed ID: 11683428
[TBL] [Abstract][Full Text] [Related]
14. [Effects of estrogen therapy on bone mass in postmenopausal women with osteopenia].
Insua A; Negri A; Zanchetta JR
Medicina (B Aires); 1995; 55(5 Pt 1):408-14. PubMed ID: 8728770
[TBL] [Abstract][Full Text] [Related]
15. Effect of replacement doses of thyroxine on bone mineral density.
Hanna FW; Pettit RJ; Ammari F; Evans WD; Sandeman D; Lazarus JH
Clin Endocrinol (Oxf); 1998 Feb; 48(2):229-34. PubMed ID: 9579237
[TBL] [Abstract][Full Text] [Related]
16. Bone mineral density in patients with endogenous subclinical hyperthyroidism: is this thyroid status a risk factor for osteoporosis?
Földes J; Tarján G; Szathmari M; Varga F; Krasznai I; Horvath C
Clin Endocrinol (Oxf); 1993 Nov; 39(5):521-7. PubMed ID: 8252739
[TBL] [Abstract][Full Text] [Related]
17. Bone mineral density in thyroxine treated females with or without a previous history of thyrotoxicosis.
Franklyn J; Betteridge J; Holder R; Daykin J; Lilley J; Sheppard M
Clin Endocrinol (Oxf); 1994 Oct; 41(4):425-32. PubMed ID: 7955453
[TBL] [Abstract][Full Text] [Related]
18. Reduced bone mass detected by bone quantitative ultrasonometry and DEXA in pre- and postmenopausal women with endogenous subclinical hyperthyroidism.
Tauchmanovà L; Nuzzo V; Del Puente A; Fonderico F; Esposito-Del Puente A; Padulla S; Rossi A; Bifulco G; Lupoli G; Lombardi G
Maturitas; 2004 Jul; 48(3):299-306. PubMed ID: 15207896
[TBL] [Abstract][Full Text] [Related]
19. Decreased serum IGF-I and dehydroepiandrosterone sulphate may be risk factors for the development of reduced bone mass in postmenopausal women with endogenous subclinical hyperthyroidism.
Földes J; Lakatos P; Zsadányi J; Horváth C
Eur J Endocrinol; 1997 Mar; 136(3):277-81. PubMed ID: 9100552
[TBL] [Abstract][Full Text] [Related]
20. Bone mineral density in pre-and post-menopausal women with affective disorder treated with long-term L-thyroxine augmentation.
Gyulai L; Bauer M; Garcia-Espana F; Hierholzer J; Baumgartner A; Berghöfer A; Whybrow PC
J Affect Disord; 2001 Oct; 66(2-3):185-91. PubMed ID: 11578671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
